newsfilter
← Latest News
GlobeNewswire·

Annovis Publishes Historical Review of Buntanetap in The Scientist

MALVERN, Pa., March 31, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for